| Application no. and date | 17020200.6 (espacenet) (Federated) (European Patent Register), 20120706 | | Patent/reg. no. and date | DK/EP 3235821, 20200408 | | Publication date | 20171025 | | Priority no. and date | EP 11005587, 20110708 | | EP pub. no. and date |
EP 3235821 20171025 | | Effective date | | | Applicant/owner | Park Therapeutics, Inc., 2031 US Highway 130
Monmouth Junction, NJ 08852, US | | Applicant ref. no. | T6169_DK | | Inventor | PRÜHS, Stefan, Wiesenweg 10
69121 Heidelberg, DE,
GRUSS, Michael, HermannstraÃYe 8
52062 Aachen, DE,
Kluge, Stefan, LörracherstraÃYe 119
4125 Riehen, CH | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61P 29/00 (2006.01) , C07D 491/107 (2006.01) | | Title | KRYSTALLINSK (1R,4R)-6'-FLUOR-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXAN-1,1'-PYRAN¬[3,4,B]INDOL]-4-AMIN | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
